Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4968 Suku-33 Novel potent inhibitor of osteoclastogenesis, suppressing both equilibrative nucleoside transporters and concentrative nucleoside transporters
DCC4969 Sul-121 Hydrochloride Novel inhibitor of airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease (COPD)
DCC4970 Sulfacetamide Antibacterial, inhibiting bacterial folic acid synthesis by competing with para amino benzoic acid
DCC4971 Sulfazecin β-Lactam antibiotic against multi-drug resistant pathogens
DCC4972 Sulfonyl Quinoxaline 1 Novel inhibitor of RhoG-hepcidin uptake
DCC4973 Sulfosuccinimidyl Oleate Sodium Neuroprotective agent, alleviating stroke-induced neuroinflammation
DCC4974 Suloctidil Hydrochloride Peripheral vasodilator
DCC4975 Sulukast Novel, potent, selective, and competitive antagonist of LTD4 and LTE4
DCC4976 Sumanirole D2 selective dopamine agonist, showing anxiolytic and anti-parkinsonian activities
DCC4977 Sun13837 Novel fibroblast growth factor receptor modulator for treating neurodegenerative diseases
DCC4978 Sun-c5174 5-HT2 antagonist
DCC4979 Supradamal Potent Inhibitor of Plasmodium FK506 Binding Protein 35 (FKBD35), also act as a HIV inhibitor
DCC4980 suvanine Antagonist of the mammalian bile acid sensor farnesoid-X-receptor (FXR)
DCC4981 Sv-293 Selective D2 dopamine receptor antagonist
DCC4982 Sv-iii-130s D2 dopamine receptor partial agonist in adenylyl cyclase inhibition assay and antagonist in the GIRK and phospho ERK1/2 assays
DCC4983 Sw208108 Novel clickable tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD)
DCC4984 Swainsonine Natural potent alpha-mannosidase inhibitor, exhibiting antimetastatic, antiproliferative, and immunomodulatory activities
DCC4985 swertisin Potent differentiating agent
DCC4986 S-y048 Novel selective OXE receptor antagonist
DCC4987 Sy-5609 Novel highly potent and selective CDK7 inhibitor, demonstrating broad anti-tumor activity in vivo
DCC4988 Syk-524 Novel universal opioid receptor agonist
DCC4989 Syk-in-ii Novel inhibitor of the Syk kinase (spleen tyrosine kinase)
DCC4990 Syn-1 Peptide Novel potent and specific inhibitor of syncytin-mediated cell fusion, completely blocking cell fusion at 1.6 μg/ml
DCC4991 Syn-1 Scr Peptide Negative control of Syn-1 peptide, having the same amino acid composition as Syn-1 peptide, but a scrambled sequence
DCC4992 syn22269076 Novel Mycobacterium tuberculosis growth inhibitor
DCC4993 Synstab A Novel microtubule-stablizer
DCC4994 Synthalin Dihydrochloride K+ channel blocker
DCC4996 Szv558 Potent inhibitor of both rodent and human MAO-B, proved to be safe in high doses with no hERG and mutagenic activities and demonstrated neuroprotection in an in vivo chronic model of PD
DCC4997 T0511-4424 Novel COX-2 inhibitor
DCC4998 T-0632 Potent and selective CCKA receptor antagonist

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X